A 30-year-old patient with dermatofibrosarcoma protuberans faced a recurrence after initial surgery. Mohs micrographic surgery was used for precise excision, reducing recurrence risk and improving outcomes.
Christopher B. Zachary, MBBS, MRCP, FRCP, shares insights in apoptosis-based skin care treatment.
Niacinamide is a versatile skincare ingredient that effectively targets acne, age-related issues, hyperpigmentation, and atopic dermatitis, writes Anjeza Fero, PharmD, RPh.
Researchers behind the latest benzene studies found no increased cancer risk with use of products containing benzoyl peroxide.
Luke Maxfield, DO, discusses the importance of understanding social media trends and engaging patients in dialogues.
Dr Darrel Rigel provides insights into cutting-edge photoprotection strategies, emphasizing the specific considerations for skin of color patients and the critical role of sunscreen in preventive dermatology.
The Omicron variant of COVID-19 is spreading quickly, jumping continents with infected travelers. Here’s the latest on what global health officials know about it.
Andrew Baker, MBA, MPAS, PA-C, discusses his role in skin cancer detection and advice for PAs interested in skin surgeries and Mohs closures.
In the final part of this Frontline Forum series, Brent Moody, MD; Sarah Arron, MD, PhD; Justine Cohen, DO; Emily Ruiz, MD, MPH; and Todd Schlesinger, MD, review 4 real-world clinical cases of BCC and the treatments they utilized.
Allergan Aesthetics recently announced the fifth-year of its partnership with Girls Inc. Nkem Ugonabo, MD, MPH, and Adelle Infante recently spoke with Dermatology Times to discuss the importance of STEM and dermatology mentorship.
Greater treatment costs are associated with more advanced stages of melanoma, particularly due to increasing prices of treatments.
Brett King, M.D, Ph.D and Alexandra Golant, M.D summarize their thoughts on optimizing treatment outcomes for patients suffering from atopic dermatitis with the JAK inhibitor class.
Dive into a complex case report of a 29-year-old African American male patient with Fitzpatrick skin type V with a 6-month reported history of vitiligo on his lips.
Experts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
CEO Daniela Marino, PhD, emphasizes that the Switzlerand based company has received Orphan Drug Designation from the Swissmedic, EMA, and FDA, for its personalized human skin graft.
Kilian Eyerich, MD, PhD, shares insights into an EADV 2024 presentation on upadacitinib’s ability to achieve almost total skin clearance in the head and neck regions with minimal effect on quality of life.
During the 2024 American Society of Clinical Oncology annual meeting, a poster highlighted the advantages Medicaid expansion could offer to individuals with melanoma.
Renata Block, MMS, PA-C, and Erica Ramos, PA-C, discuss the complexities of developing an over-the-counter hair product.
A panel of experts discusses tailoring treatment to patient needs, supporting patients' mental health, and considering future directions.
Dermatologists Jeanine Downie, DiAnne Davis, and Hope Mitchell reveal the La Roche-Posay products they recommend to patients with dry skin, eczema, and more, at the flagship store in France.
Bar will share insight on foldover interpolated flaps for full thickness of nasal defects.
Two new forms of Trichophyton mentagrophytes type VII and Trichophyton indotineae are emerging, according to a new report.
Brauer’s textbook can be purchased through Amazon and Barnes & Noble.
Data presented at the American Academy of Dermatology 2022 Annual Meeting shows what supplements can and cannot manage alopecia areata.
Alan Irvine, MD, DSc, shares insights on the impact of ruxolitinib on quality of life in pediatric patients and 2024 AAD research presentations to take into consideration.
Sachin Shridharani, MD, FACS, discusses the READY-1 and READY-2 clinical trials and positive support for Relfydess.
Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
An expert in dermatology shares his insights into the management considerations with traditionally utilized treatments for generalized pustular psoriasis and discusses the impact of a recent approval in this space.
Defining the goals of the mentoring relationship can be useful to clarify expectations.